Target intelligence / Profile preview

c-MYC promoter G-quadruplex DNA (c-MYC G4)

Target
c-MYC G4
Molecular classification
Nucleic acid, Non-canonical DNA structure, Gene promoter element
01

Overview

The c-MYC G-quadruplex is a non-canonical DNA secondary structure located within the Nuclease Hypersensitive Element III1 (NHE III1) of the c-MYC gene promoter (Brooks & Hurley, 2009). This region is responsible for the majority of c-MYC transcriptional activity and contains a guanine-rich sequence that can fold into a stable four-stranded structure known as a G-quadruplex (Siddiqui-Jain et al., 2002). When formed, this structure acts as a transcriptional silencer by physically blocking the progression of RNA polymerase and other transcription factors. Because c-MYC is a master regulator of cell proliferation and is frequently overexpressed in human cancers, this DNA structure represents a high-value therapeutic target (Balasubramanian et al., 2011). Small molecule ligands are designed to stabilize the G-quadruplex, often utilizing interactions with the adjacent A-T rich minor groove to enhance binding affinity and target specificity. Successfully downregulating c-MYC through G-quadruplex stabilization leads to inhibited tumor growth and the induction of apoptosis in cancer cells.

Other names
c-MYC G-quadruplexNHE III1 G-quadruplexc-MYC Pu27 G-quadruplexMYC promoter G4 DNAc-MYC G4
02

Mechanism of action

Stabilization of the G-quadruplex structure within the c-MYC promoter region to sterically inhibit transcription and downregulate MYC oncogene expression.

03

Biological functions

Regulation of transcriptionGene expression controlChromatin remodelingDNA structural transition
04

Disease associations

CancerBurkitt lymphomaBreast cancerProstate cancerHematologic malignancy
05

Safety considerations

Off-target binding to other genomic G-quadruplexes (e.g., telomeres)Potential for widespread genomic instabilityToxicity in normal regenerative tissues due to MYC essentialityChallenges in achieving high structural selectivity
06

Interacting drugs

Quarfloxin (CX-3543)

4 more in the full profile.

07

Biomarkers

c-MYC protein expression levelsMYC mRNA levelsG-quadruplex formation (detected via BG4 antibody)

Beyond the preview

Go deeper on c-MYC promoter G-quadruplex DNA (c-MYC G4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on c-MYC promoter G-quadruplex DNA (c-MYC G4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call